MAPK signalling in cellular metabolism: Stress or wellness?

EMBO Reports

Volumn 11, Issue 11, 2010, Pages 834-840

  Gehart, Helmuth ^a,b   Kumpf, Susann ^a   Ittner, Arne ^a,b   Ricci, Romeo ^a,b,c  

^a ETH ZURICH   (Switzerland)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

diabetes; insulin signalling; MAPapK; metabolism; obesity

Indexed keywords

INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ADIPOCYTE; CELL FUNCTION; CELL MATURATION; CELL METABOLISM; DIET RESTRICTION; HUMAN; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS; WELLBEING;

ADIPOCYTES; ANIMALS; CELLS; HUMANS; INSULIN; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; STRESS, PHYSIOLOGICAL;

EID: 78049339834     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2010.160     Document Type: Review

References (52)

1. Anjum R, Blenis J (2008) the rSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 9: 747-758
2. Antonescu CN, Huang C, Niu W, Liu Z, Eyers PA, Heidenreich KA, Bilan PJ, Klip A (2005) reduction of insulin-stimulated glucose uptake in L6 myotubes by the protein kinase inhibitor SB203580 is independent of p38MapK activity. Endocrinology 146: 3773-3781
3. Asada S et al (2007) Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell Signal 19: 519-527
4. Avruch J (1998) insulin signal transduction through protein kinase cascades. Mol Cell Biochem 182: 31-48
5. Bost F, Caron L, Marchetti I, Dani C, LE Marchand-Brustel Y, Binetruy B (2002) retinoic acid activation of the ErK pathway is required for embryonic stem cell commitment into the adipocyte lineage. Biochem J 361: 621-627
6. Bost F et al (2005) the extracellular signal-regulated kinase isoform ErK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54: 402-411
7. Burns CJ, Squires PE, Persaud SJ (2000) Signaling through the p38 and p42/44 mitogen-activated families of protein kinases in pancreatic β-cell proliferation. Biochem Biophys Res Commun 268: 541-546
8. Cao W, Collins QF, Becker TC, Robidoux J, Lupo Eg Jr, Xiong Y, Daniel KW, Floering L, Collins S (2005) p38 Mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis. J Biol Chem 280: 42731-42737
9. Copps KD, Hancer NJ, Opare-ado L, Qiu W, Walsh C, White MF (2010) irs1 serine 307 promotes insulin sensitivity in mice. Cell Metab 11: 84-92
10. Cross DA, Alessi Dr, Cohen P, Andjelkovich M, Hemmings BA (1995) inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789
11. Deak M, Clifton AD, Lucocq LM, Alessi DR (1998) Mitogen-and stress-activated protein kinase-1 (MSK1) is directly activated by MapK and SapK2/p38, and may mediate activation of crEB. EMBO J 17: 4426-4441
12. Despres JP, Lemieux I (2006) abdominal obesity and metabolic syndrome. Nature 444: 881-887
13. Dhillon AS, Hagan S, Rath O, Kolch W (2007) Map kinase signalling pathways in cancer. Oncogene 26: 3279-3290
14. Dufresne SD, Bjorbaek C, El-Haschimi K, Zhao Y, Aschenbach WG, Moller DE, goodyear LJ (2001) altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice. Mol Cell Biol 21: 81-87
15. Eldar-Finkelman H, Argast GM, Foord O, Fischer EH, Krebs EG (1996) Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells. Proc Natl Acad Sci USA 93: 10228-10233
16. Engelman JA, Lisanti MP, Scherer PE (1998) Specific inhibitors of p38 mitogen-activated protein kinase block 3t3-L1 adipogenesis. J Biol Chem 273: 32111-32120
17. Font de Mora J, Esteban LM, Burks DJ, Nunez A, Garces C, Garcia-Barrado MJ, iglesias-Osma MC, Moratinos J, Ward JM, Santos E (2003) ras-grF1 signaling is required for normal beta-cell development and glucose homeostasis. EMBO J 22: 3039-3049
18. Goldstein JL, DeBose-Boyd RA, Brown MS (2006) protein sensors for membrane sterols. Cell 124: 35-46
19. Greenberg AS, Shen WJ, Muliro K, Patel S, Souza SC, Roth RA, Kraemer FB (2001) Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway. J Biol Chem 276: 45456-45461
20. Gross DN, Wan M, Birnbaum MJ (2009) the role of FOXO in the regulation of metabolism. Curr Diab Rep 9: 208-214
21. Hata K, Nishimura R, Ikeda F, Yamashita K, Matsubara T, Nokubi T, Yoneda T (2003) Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis. Mol Biol Cell 14: 545-555
22. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS (2002) a central role for JNK in obesity and insulin resistance. Nature 420: 333-336
23. Hotamisligil GS (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140: 900-917
24. Hu E, Kim JB, Sarraf P, Spiegelman BM (1996) inhibition of adipogenesis through Map kinase-mediated phosphorylation of ppargamma. Science 274: 2100-2103
25. Imai J et al (2008) regulation of pancreatic beta cell mass by neuronal signals from the liver. Science 322: 1250-1254
26. Itoh M, Adachi M, Yasui H, Takekawa M, Tanaka H, Imai K (2002) Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol Endocrinol 16: 2382-2392
27. Juge-aubry CE, Hammar E, Siegrist-Kaiser C, pernin A, Takeshita A, Chin WW, Burger AG, Meier CA (1999) regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain. J Biol Chem 274: 10505-10510
28. Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka TA, Matsuhisa M, Yamasaki Y (2005) role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance. Int J Biochem Cell Biol 37: 1595-1608
29. Kim KA, Kim JH, Wang Y, Sul HS (2007) pref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation. Mol Cell Biol 27: 2294-2308
30. Kotzka J, Lehr S, Roth G, Avci H, Knebel B, Muller-Wieland D (2004) insulin-activated Erk-mitogen-activated protein kinases phosphorylate sterol regulatory element-binding protein-2 at serine residues 432 and 455 in vivo. J Biol Chem 279: 22404-22411
31. Krstic MD, Rogatsky I, Yamamoto KR, Garabedian MJ (1997) Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol Cell Biol 17: 3947-3954
32. Lee SJ, Pfluger PT, Kim JY, Nogueiras R, Duran A, Pages G, Pouyssegur J, Tschop MH, Diaz-Meco Mt, Moscat J (2010) a functional role for the p62-ErK1 axis in the control of energy homeostasis and adipogenesis. EMBO Rep 11: 226-232
33. Maekawa T, Jin W, Ishii S (2010) the role of atF-2 family transcription factors in adipocyte differentiation: antiobesity effects of p38 inhibitors. Mol Cell Biol 30: 613-625
34. Martin S, Parton RG (2006) Lipid droplets: a unified view of a dynamic organelle. Nat Rev Mol Cell Biol 7: 373-378
35. Mayr B, Montminy M (2001) transcriptional regulation by the phosphorylation-dependent factor crEB. Nat Rev Mol Cell Biol 2: 599-609
36. Miller AL, Webb MS, Copik AJ, Wang Y, Johnson BH, Kumar R, Thompson EB (2005) p38 Mitogen-activated protein kinase (MapK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MapK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol 19: 1569-1583
37. Moxham CM, Tabrizchi A, Davis RJ, Malbon CC (1996) Jun N-terminal kinase mediates activation of skeletal muscle glycogen synthase by insulin in vivo. J Biol Chem 271: 30765-30773
38. Pronk GJ, Mcglade J, Pelicci G, Pawson T, Bos JL (1993) insulin-induced phosphorylation of the 46-and 52-kDa Shc proteins. J Biol Chem 268: 5748-5753
39. Puigserver P, Rhee J, Lin J, Wu Z, Yoon JC, Zhang CY, Krauss S, Mootha VK, Lowell BB, Spiegelman BM (2001) cytokine stimulation of energy expenditure through p38 Map kinase activation of pparγ coactivator-1. Mol Cell 8: 971-982
40. Qiao L, MacDougald OA, Shao J (2006) ccaat/enhancer-binding protein alpha mediates induction of hepatic phosphoenolpyruvate carboxykinase by p38 mitogen-activated protein kinase. J Biol Chem 281: 24390-24397
41. Ribe D, Yang J, Patel S, Koumanov F, Cushman SW, Holman gD (2005) Endofacial competitive inhibition of glucose transporter-4 intrinsic activity by the mitogen-activated protein kinase inhibitor SB203580. Endocrinology 146: 1713-1717
42. Roth G, Kotzka J, Kremer L, Lehr S, Lohaus C, Meyer HE, Krone W, Muller-Wieland D (2000) Map kinases Erk1/2 phosphorylate sterol regulatory element-binding protein (SrEBp)-1a at serine 117 in vitro. J Biol Chem 275: 33302-33307
43. Ryden M, Arvidsson E, Blomqvist L, Perbeck L, Dicker A, Arner P (2004) targets for tNF-alpha-induced lipolysis in human adipocytes. Biochem Biophys Res Commun 318: 168-175
44. Sabio G, Davis RJ (2010) cJun NH(2)-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance. Trends Biochem Sci 35: 490-496
45. Sabio G, Cavanagh-Kyros J, Ko HJ, Jung DY, Gray S, Jun JY, Barrett T, Mora A, Kim JK, Davis RJ (2009) prevention of steatosis by hepatic JNK1. Cell Metab 10: 491-498
46. Sale EM, atkinson PG, Sale GJ (1995) requirement of Map kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNa synthesis. EMBO J 14: 674-684
47. Sumara G et al (2009) regulation of pKD by the MapK p38delta in insulin secretion and glucose homeostasis. Cell 136: 235-248
48. Sutherland C, Leighton IA, Cohen P (1993) inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296: 15-19
49. Taniguchi CM, Aleman JO, Ueki K, Luo J, Asano T, Kaneto H, Stephanopoulos G, Cantley LC, Kahn CR (2007) the p85alpha regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinase-mediated insulin resistance. Mol Cell Biol 27: 2830-2840
50. Tseng YH et al (2008) New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454: 1000-1004
51. Waeber G et al (2000) the gene MapK8ip1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat Genet 24: 291-295
52. Xiong Y, Collins QF, An J, Lupo E Jr, Liu Hy, Liu D, Robidoux J, Liu Z, Cao W (2007) p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis. J Biol Chem 282: 4975-4982